Insider trades appear within seconds, the rest within the hour.

Get alerts

← Feed

SGPNasdaq

SpyGlass Pharma, Inc.

Alert me on SGP
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

After each filing

24
Feb 12 Buy Florence Anthony A. Jr. Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy RA CAPITAL MANAGEMENT, L.P. Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy RA Capital Healthcare Fund LP Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy RA Capital Nexus Fund III, L.P. Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy Kolchinsky Peter Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Show all 24
Feb 12 Buy Shah Rajeev M. Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy Khan Bilal Arshad Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy Pardo Geoffrey B Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy Mathers Edward T Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy Behbahani Ali Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy Yang Rick Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy Chang Carmen Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy Makhzoumi Mohamad Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy SANDELL SCOTT D Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy BASKETT FOREST Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy Walker Paul Edward Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy New Enterprise Associates 17, L.P. Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy NEA Partners 17, L.P. Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 12 Buy NEA 17 GP, LLC Insider
1 week
+6.6%S&P +1.2%
1 month
−1.5%S&P −1.8%
3 months
−11.7%S&P +10.1%
6 months
−4.7%S&P +14.6%
Feb 11 Buy Nielsen Kirk G. Insider
1 week
+7.7%S&P −1.1%
1 month
−3.6%S&P −4.3%
3 months
−13.5%S&P +7.6%
6 months
−8.6%S&P +13.0%
Feb 11 Buy Vensana Capital I GP, LLC Insider
1 week
+7.7%S&P −1.1%
1 month
−3.6%S&P −4.3%
3 months
−13.5%S&P +7.6%
6 months
−8.6%S&P +13.0%
Feb 11 Buy Vensana Capital I, L.P. Insider
1 week
+7.7%S&P −1.1%
1 month
−3.6%S&P −4.3%
3 months
−13.5%S&P +7.6%
6 months
−8.6%S&P +13.0%
Feb 11 Buy Nielsen Kirk G. Insider
1 week
+7.7%S&P −1.1%
1 month
−3.6%S&P −4.3%
3 months
−13.5%S&P +7.6%
6 months
−8.6%S&P +13.0%
Feb 11 Buy Klein Peter Justin Insider
1 week
+7.7%S&P −1.1%
1 month
−3.6%S&P −4.3%
3 months
−13.5%S&P +7.6%
6 months
−8.6%S&P +13.0%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for SGP

36 held · newest 536 held · newest 2
Loading the filings.
See all 36 filings for SGP

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
No lobbying reports on file.